Recombinant tissue plasminogen activators (rtPA): A review

Thrombolytics in Acute Ischaemic Stroke: Historical Perspective and Future Opportunities

(2013) Joachim Röther et al.   CEREBROVASCULAR DISEASES

Advanced multimodal CT/MRI approaches to hyperacute stroke diagnosis, treatment, and monitoring

(2012) David S. Liebeskind et al.   Annals of the New York Academy of Sciences

Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review

(2012) Nazeeha Hasan et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Pulmonary embolism: risk assessment and management

(2012) S. Konstantinides et al.   EUROPEAN HEART JOURNAL

Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle

(2012) Jyh-Ping Chen et al.   International Journal of Nanomedicine

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

(2012)   LANCET

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

(2012) Joanna M Wardlaw et al.   LANCET

A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke

(2012) Mark Parsons et al.   NEW ENGLAND JOURNAL OF MEDICINE

IL1B and VWF Variants Are Associated With Fibrinolytic Early Recanalization in Patients With Ischemic Stroke

(2012) Israel Fernández-Cadenas et al.   STROKE

Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: An approach for localized thrombolysis

(2012) Shahriar Absar et al.   THROMBOSIS RESEARCH

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension

(2011) Michael R. Jaff et al.   CIRCULATION

Ultrasound-responsive thrombus treatment with zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator

(2011) Yoshiko Uesugi et al.   JOURNAL OF DRUG TARGETING

Intra-arterial Therapy for Acute Ischemic Stroke

(2011) Alex Abou-Chebl   Neurotherapeutics

A Controlled Trial of a Prostacyclin and rt-PA in the Treatment of Severe Frostbite

(2011) Emmanuel Cauchy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model

(2011) Susan T. Laing et al.   THROMBOSIS RESEARCH

Wilderness Medical Society Practice Guidelines for the Prevention and Treatment of Frostbite

(2011) Scott E. McIntosh et al.   WILDERNESS & ENVIRONMENTAL MEDICINE

Frostbites in circumpolar areas

(2011) Tiina Maria Ikäheimo et al.   Global Health Action

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies

(2010) C. Longstaff et al.   BLOOD

Therapy for acute high-risk pulmonary embolism: thrombolytic therapy and embolectomy

(2010) Nicolas Meneveau   CURRENT OPINION IN CARDIOLOGY

The Tissue-Type Plasminogen Activator Story

(2009) D. Collen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

An implantable MEMS drug delivery device for rapid delivery in ambulatory emergency care

(2009) N. M. Elman et al.   BIOMEDICAL MICRODEVICES

Basic mechanisms and pathogenesis of venous thrombosis

(2009) Charles T. Esmon   BLOOD REVIEWS

Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke

(2009) Maarten G. Lansberg et al.   STROKE

Mechanisms of Thrombus Formation

(2008) Bruce Furie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Translational Medicine for Stroke Drug Discovery: The Pharmaceutical Industry Perspective

(2008) G. Z. Feuerstein et al.   STROKE